Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea.
Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C. Dang C, et al. Among authors: hudis c. J Clin Oncol. 2010 Jun 20;28(18):2982-8. doi: 10.1200/JCO.2009.26.5900. Epub 2010 May 17. J Clin Oncol. 2010. PMID: 20479410 Free PMC article. Clinical Trial.
High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J, Vahdat L, Fennelly D, Francis P, Wasserheit C, Hudis C, Kritz A, Schneider J, Hamilton N, Gilewski T, et al. Crown J, et al. Among authors: hudis c. Ann N Y Acad Sci. 1993 Nov 30;698:378-88. doi: 10.1111/j.1749-6632.1993.tb17230.x. Ann N Y Acad Sci. 1993. PMID: 7506505 Review.
High-dose chemotherapy of breast cancer.
Crown J, Raptis G, Hamilton N, Hudis C, Vahclat L, Fennelly D, Norton L. Crown J, et al. Among authors: hudis c. Can J Oncol. 1995 Dec;5 Suppl 1:80-2. Can J Oncol. 1995. PMID: 8853530 Review.
Phase II study of semisynthetic paclitaxel in metastatic breast cancer.
Hudis C, Riccio L, Holmes F, Seidman A, Baselga J, Currie V, Fennelly D, Gilewski T, Moynahan M, Raptis G, Sklarin N, Surbone A, Uhlenhopp M, Maickel N, Yao TJ, Hellmann S, Usakewicz J, Hortobagyi G, Norton L. Hudis C, et al. Eur J Cancer. 1997 Nov;33(13):2198-202. doi: 10.1016/s0959-8049(97)00254-2. Eur J Cancer. 1997. PMID: 9470806 Clinical Trial.
Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel.
Hudis C, Riccio L, Seidman A, Baselga J, Currie V, Fennelly D, Gilewski T, Lebwohl D, Moynahan M, Raptis G, Surbone A, Sklarin N, Yao TJ, Keefe D, Norton L. Hudis C, et al. Cancer Invest. 1998;16(2):67-71. doi: 10.3109/07357909809039759. Cancer Invest. 1998. PMID: 9512671 Clinical Trial. No abstract available.
508 results